ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Re-sting risk after stopping venom immunotherapy in relation to severity of pretreatment reaction

Re-sting risk after stopping venom immunotherapy in relation to severity of pretreatment reaction
Author Mild PTR (I to II)* Severe PTR (III to IV)*
Number of patients Number with SAR (percentage) Number of patients Number with SAR (percentage)
Golden[1] 10 1 (10) 18 5 (28)
Keating[2] 30 0 15 2 (13)
Reisman[3] 66 3 (4.5) 47 7 (15)
Lerch[4] 17 1 (6) 183 24 (13)
Total 123 4 (4) 263 38 (14.5)
PTR: pretreatment reaction; SAR: systemic allergic reaction.
* Grade of severity according to Mueller[5].
¶ x2 = 11.32; p<0.001.
References:
  1. Golden DB, Johnson K, Addison BI, et al. Clinical and immunologic observations in patients who stop venom immunotherapy. J Allergy Clin Immunol 1986; 77:435.
  2. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991; 88:339.
  3. Reisman RE. Duration of venom immunotherapy: Relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 1993; 92:831.
  4. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patients. J Allergy Clin Immunol 1998; 101:606.
  5. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966; 3:331.
Graphic 51249 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟